Presynaptic APP levels and synaptic homeostasis are regulated by Akt phosphorylation of Huntingtin

  1. Julie Bruyère
  2. Yah-Se Abada
  3. Hélène Marine Vitet
  4. Gaëlle Fontaine
  5. Jean-Christophe Deloulme
  6. Aurélia Cès
  7. Eric Denarier
  8. Karin Pernet-Gallay
  9. Annie Andrieux
  10. Sandrine Humbert
  11. Marie-Claude Potier
  12. Benoît Delatour
  13. Frédéric Saudou  Is a corresponding author
  1. University Grenoble Alpes, France
  2. Sorbonne Université, France
  3. Institut du Cerveau et de la Moelle épinière, ICM, France

Abstract

Studies have suggested that amyloid precursor protein (APP) regulates synaptic homeostasis, but the evidence has not been consistent. In particular, signaling pathways controlling APP transport to the synapse in axons and dendrites remain to be identified. Having previously shown that Huntingtin (HTT), the scaffolding protein involved in Huntington's disease, regulates neuritic transport of APP, we used a microfluidic corticocortical neuronal network-on-a-chip to examine APP transport and localization to the pre- and post-synaptic compartments. We found that HTT, upon phosphorylation by the Ser/Thr kinase Akt, regulates APP transport in axons but not dendrites. Expression of an unphosphorylatable HTT decreased axonal anterograde transport of APP, reduced presynaptic APP levels, and increased synaptic density. Ablating in vivo HTT phosphorylation in APPPS1 mice, which overexpress APP, reduced presynaptic APP levels, restored synapse number and improved learning and memory. The Akt-HTT pathway and axonal transport of APP thus regulate APP presynaptic levels and synapse homeostasis.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files.

Article and author information

Author details

  1. Julie Bruyère

    INSERM U1216, Grenoble Institut Neurosciences, University Grenoble Alpes, Grenoble, France
    Competing interests
    No competing interests declared.
  2. Yah-Se Abada

    Institut du Cerveau et de la Moelle épinière, ICM, Inserm U1127, CNRS UMR 7225, Sorbonne Université, Paris, France
    Competing interests
    No competing interests declared.
  3. Hélène Marine Vitet

    INSERM U1216, Grenoble Institut Neurosciences, University Grenoble Alpes, Grenoble, France
    Competing interests
    No competing interests declared.
  4. Gaëlle Fontaine

    Institut du Cerveau et de la Moelle épinière, ICM, Inserm U1127, CNRS UMR 7225, Sorbonne Université, Paris, France
    Competing interests
    No competing interests declared.
  5. Jean-Christophe Deloulme

    Inserm U 1216 Grenoble Institut Neurosciences, University Grenoble Alpes, Grenoble, France
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2234-5865
  6. Aurélia Cès

    Institut du Cerveau et de la Moelle épinière, ICM, Inserm U1127, CNRS UMR 7225, Sorbonne Université, Paris, France
    Competing interests
    No competing interests declared.
  7. Eric Denarier

    Inserm U 1216 Grenoble Institut Neurosciences, University Grenoble Alpes, Grenoble, France
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4169-397X
  8. Karin Pernet-Gallay

    INSERM U1216, Grenoble Institut Neurosciences, University Grenoble Alpes, Grenoble, France
    Competing interests
    No competing interests declared.
  9. Annie Andrieux

    Inserm U1216, CEA, Grenoble Institut Neurosciences, University Grenoble Alpes, Grenoble, France
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4022-6405
  10. Sandrine Humbert

    INSERM U1216, Grenoble Institut Neurosciences, University Grenoble Alpes, Grenoble, France
    Competing interests
    No competing interests declared.
  11. Marie-Claude Potier

    Inserm U1127, CNRS UMR 7225, Sorbonne Universités, UPMC Univ Paris 06 UMRS 1127, Institut du Cerveau et de la Moelle épinière, ICM, Paris, France
    Competing interests
    No competing interests declared.
  12. Benoît Delatour

    Institut du Cerveau et de la Moelle épinière, ICM, Inserm U1127, CNRS UMR 7225, Sorbonne Université, Paris, France
    Competing interests
    No competing interests declared.
  13. Frédéric Saudou

    INSERM U1216, Grenoble Institut Neurosciences, University Grenoble Alpes, Grenoble, France
    For correspondence
    frederic.saudou@inserm.fr
    Competing interests
    Frédéric Saudou, is on the scientific advisory board of Servier (Neurosciences Department) and a consultant for TEVA and Wave Life Sciences. The other authors declare that they have no competing interests..
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6107-1046

Funding

Agence Nationale de la Recherche (ANR-12-MALZ-0004 HuntAbeta)

  • Frédéric Saudou

Agence Nationale de la Recherche (ANR-15-IDEX-02 NeuroCoG)

  • Frédéric Saudou

Agence Nationale de la Recherche (ANR-10-IAIHU-06)

  • Marie-Claude Potier

Fondation pour la Recherche Médicale (DEQ20170336752)

  • Sandrine Humbert

Fondation pour la Recherche Médicale (FDT201904008035)

  • Hélène Marine Vitet

Fondation pour la Recherche Médicale (DEI20151234418)

  • Frédéric Saudou

Fondation pour la Recherche sur le Cerveau

  • Frédéric Saudou

INSERM (AGEMED)

  • Frédéric Saudou

Fondation Bettencourt Schueller

  • Frédéric Saudou

Association Huntington France

  • Hélène Marine Vitet

Agence Nationale de la Recherche (ANR-12-MALZ-0004 HuntAbeta)

  • Marie-Claude Potier

INSERM (AGEMED)

  • Sandrine Humbert

Agence Nationale de la Recherche (ANR-14-CE35-0027-01 PASSAGE)

  • Frédéric Saudou

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: Animals were held in accordance with the French Animal Welfare Act and the EU legislation (Council Directive 86/609/EEC) and the ARRIVE (Animal Research: Reporting of In Vivo Experiments) guidelines. The French Ministry of Agriculture and the local ethics committee gave specific authorization (authorization no. 04594.02) to BD to conduct the experiments described in the present study.

Reviewing Editor

  1. Harry T Orr, University of Minnesota, United States

Publication history

  1. Received: February 25, 2020
  2. Accepted: May 11, 2020
  3. Accepted Manuscript published: May 26, 2020 (version 1)
  4. Version of Record published: June 3, 2020 (version 2)

Copyright

© 2020, Bruyère et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,847
    Page views
  • 327
    Downloads
  • 12
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Julie Bruyère
  2. Yah-Se Abada
  3. Hélène Marine Vitet
  4. Gaëlle Fontaine
  5. Jean-Christophe Deloulme
  6. Aurélia Cès
  7. Eric Denarier
  8. Karin Pernet-Gallay
  9. Annie Andrieux
  10. Sandrine Humbert
  11. Marie-Claude Potier
  12. Benoît Delatour
  13. Frédéric Saudou
(2020)
Presynaptic APP levels and synaptic homeostasis are regulated by Akt phosphorylation of Huntingtin
eLife 9:e56371.
https://doi.org/10.7554/eLife.56371

Further reading

    1. Cell Biology
    2. Neuroscience
    Holly H Black, Jessica L Hanson ... Alexandra Whiteley
    Research Article

    Amyotrophic Lateral Sclerosis (ALS) is a fatal neurodegenerative disease characterized by progressive motor neuron dysfunction and loss. A portion of ALS cases are caused by mutation of the proteasome shuttle factor Ubiquilin 2 (UBQLN2), but the molecular pathway leading from UBQLN2 dysfunction to disease remains unclear. Here, we demonstrate that UBQLN2 regulates the domesticated gag-pol retrotransposon 'paternally expressed gene 10' (PEG10) in human cells and tissues. In cells, the PEG10 gag-pol protein cleaves itself in a mechanism reminiscent of retrotransposon self-processing to generate a liberated 'nucleocapsid' fragment, which uniquely localizes to the nucleus and changes the expression of genes involved in axon remodeling. In spinal cord tissue from ALS patients, PEG10 gag-pol is elevated compared to healthy controls. These findings implicate the retrotransposon-like activity of PEG10 as a contributing mechanism in ALS through regulation of gene expression, and restraint of PEG10 as a primary function of UBQLN2.

    1. Cell Biology
    Yucen Hu, Jingxiu Xu ... Weirui Ma
    Tools and Resources Updated

    Imaging endogenous mRNAs in live animals is technically challenging. Here, we describe an MS2-based signal amplification with the Suntag system that enables live-cell RNA imaging of high temporal resolution and with 8xMS2 stem-loops, which overcomes the obstacle of inserting a 1300 nt 24xMS2 into the genome for the imaging of endogenous mRNAs. Using this tool, we were able to image the activation of gene expression and the dynamics of endogenous mRNAs in the epidermis of live C. elegans.